International Clinical Trial: A study to see if the drug Somatostatin can protect the new liver and kidneys in patients undergoing living donor liver transplant surgery

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119278) titled 'A study to see if the drug Somatostatin can protect the new liver and kidneys in patients undergoing living donor liver transplant surgery' on Oct. 9.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Stratified block randomization Method of allocation concealment:On-site computer system Blinding and masking:Participant and Investigator Blinded

Primary Sponsor: Prasanna Gopal

Condition: Health Condition 1: K72- Hepatic failure, not elsewhere classified Health Condition 2: K704- Alcoholic hepatic failure Health Cond...